Recursion (NASDAQ: RXRX) investors back board nominees and PwC as 2026 auditor
Rhea-AI Filing Summary
Recursion Pharmaceuticals, Inc. reported the results of its 2026 annual stockholder meeting held on June 17, 2026. Stockholders elected Class II directors Najat Khan, Ph.D., and Franziska Michor, Ph.D., to serve until the 2029 annual meeting or until successors are elected and qualified.
Stockholders also approved, on an advisory basis, the Company’s executive compensation, with 206,171,008 votes for, 30,893,147 against, and 1,280,852 abstentions, plus 126,675,762 broker non-votes. In addition, they ratified the appointment of PricewaterhouseCoopers LLP as independent registered public accounting firm for the year ending December 31, 2026, with 361,743,500 votes for, 2,148,771 against, and 1,128,498 abstentions.
Positive
- None.
Negative
- None.
8-K Event Classification
Item 5.07 — Submission of Matters to a Vote of Security Holders
1 item
Item 5.07
Submission of Matters to a Vote of Security Holders
Governance
Results of a shareholder vote on proposals at an annual or special meeting.
Key Figures
Votes for Najat Khan, Ph.D.: 210,437,751 votes
Votes for Franziska Michor, Ph.D.: 208,124,737 votes
Executive compensation advisory approval: 206,171,008 votes for
+3 more
6 metrics
Votes for Najat Khan, Ph.D.
210,437,751 votes
Election as Class II director at 2026 annual meeting
Votes for Franziska Michor, Ph.D.
208,124,737 votes
Election as Class II director at 2026 annual meeting
Executive compensation advisory approval
206,171,008 votes for
Say-on-pay resolution at 2026 annual meeting
Broker non-votes on say-on-pay
126,675,762 votes
Executive compensation advisory vote
Auditor ratification votes for PwC
361,743,500 votes for
Ratification of independent registered public accounting firm for 2026
Votes against PwC ratification
2,148,771 votes
Auditor ratification at 2026 annual meeting
Key Terms
broker non-votes, advisory resolution, executive compensation, independent registered public accounting firm, +1 more
5 terms
broker non-votes financial
"The voting results were as follows Najat Khan, Ph.D. | 210,437,751 | 27,907,256 | 126,675,762 broker non-votes"
Broker non-votes occur when a brokerage firm is unable to vote on a shareholder’s behalf during a company election or decision because the shareholder has not given specific voting instructions, and the broker is not allowed or chooses not to vote on certain matters. They are important because they can affect the outcome of votes, especially when the results are close, by effectively reducing the total number of votes cast.
advisory resolution financial
"The advisory resolution to approve executive compensation, as disclosed in the Proxy Statement, was approved"
An advisory resolution is a non-binding vote by shareholders that expresses their opinion on a specific corporate matter, such as executive pay or a governance policy. It matters to investors because, like a public survey, it signals shareholder sentiment to the board and management; even though it does not force action, a strong vote for or against can prompt changes, affect company reputation, and influence future decisions that impact shareholder value.
executive compensation financial
"The advisory resolution to approve executive compensation, as disclosed in the Proxy Statement, was approved"
Payments and benefits given to a company's top leaders — including base salary, cash bonuses, stock awards, options and retirement or perquisites — designed to compensate and motivate them. Investors care because these packages affect a company’s costs, influence executives’ decisions and signal how well management’s interests line up with shareholders’; like a captain’s contract, the structure of pay can encourage safe navigation toward long-term gains or risky short-term moves that hurt returns.
independent registered public accounting firm financial
"The appointment of PricewaterhouseCoopers LLP as independent registered public accounting firm for the year ending December 31, 2026 was ratified"
An independent registered public accounting firm is an outside accounting company officially registered with the government regulator to examine and report on a public company's financial records and controls. Investors treat its reports like an impartial inspector’s certificate — they add credibility to financial statements, help spot errors or misleading claims, and reduce the risk that shareholders are relying on unchecked or biased numbers.
annual meeting of stockholders financial
"Recursion Pharmaceuticals, Inc. held its 2026 annual meeting of stockholders"
FAQ
Who was elected to Recursion Pharmaceuticals’ board at the 2026 annual meeting?
Shareholders elected Najat Khan, Ph.D., and Franziska Michor, Ph.D., as Class II directors to serve until the 2029 annual meeting, or until their successors are duly elected and qualified, reinforcing the current board structure for Recursion Pharmaceuticals.
Was the auditor ratified at Recursion Pharmaceuticals’ 2026 annual meeting?
Yes. Shareholders ratified PricewaterhouseCoopers LLP as Recursion Pharmaceuticals’ independent registered public accounting firm for the year ending December 31, 2026, with 361,743,500 votes for, 2,148,771 against, and 1,128,498 abstentions.
What were the vote totals for director Najat Khan at Recursion Pharmaceuticals’ 2026 meeting?
For director nominee Najat Khan, Ph.D., shareholders cast 210,437,751 votes for, 27,907,256 withheld, and recorded 126,675,762 broker non-votes, resulting in her election as a Class II director through the 2029 annual meeting.
What were the vote totals for director Franziska Michor at Recursion Pharmaceuticals’ 2026 meeting?
For director nominee Franziska Michor, Ph.D., shareholders cast 208,124,737 votes for, 30,220,270 withheld, and recorded 126,675,762 broker non-votes, leading to her election as a Class II director serving until the 2029 annual meeting.
AI-generated analysis. How Rhea-AI works. Not financial advice.
